Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
3.490
-0.940 (-21.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Five Companies Developing Second Generation Psychedelics For Mental Health
↗
March 24, 2022
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...
Via
Benzinga
58 Biggest Movers From Yesterday
↗
March 24, 2022
Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...
Via
Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
↗
March 09, 2022
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
↗
March 08, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
March 01, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 172.1% to $0.92 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 157.8...
Via
Benzinga
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
↗
February 22, 2022
Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. ...
Via
Benzinga
Psilocybin For Cancer Related Distress: Enveric To Launch Clinical Trial In Partnership With University of Calgary
↗
February 17, 2022
Enveric Biosciences (NASDAQ:ENVB) a neuroscience company d...
Via
Benzinga
Enveric Biosciences Closes $10 Million Public Offering
↗
February 16, 2022
Psychedelics-based company Enveric Biosciences (NASDAQ:ENVB
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 11, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 16, 2022
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low...
Via
Benzinga
78 Biggest Movers From Friday
↗
February 14, 2022
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...
Via
Benzinga
Mid-Afternoon Market Update: US Stocks Extend Losses; Dow Tumbles 450 Points
↗
February 11, 2022
US stocks extended losses toward the end of trading session, with the Dow Jones tumbling 450 points on Friday.
Via
Benzinga
52 Weeks High And Low Article
↗
February 11, 2022
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...
Via
Benzinga
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
↗
February 11, 2022
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday.
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
↗
February 11, 2022
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...
Via
Benzinga
Enveric Biosciences Shares Fall After $10M Equity Raise
↗
February 11, 2022
Enveric Biosciences Inc (NASDAQ: ENVB) has priced its previously announced underwritten public offering of 20 million shares and warrants to purchase up to 20 million shares...
Via
Benzinga
23 Stocks Moving in Friday's Pre-Market Session
↗
February 11, 2022
Gainers Modular Medical Inc (NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, reported pricing of $15 million public offering...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 10, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI)...
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
↗
February 09, 2022
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...
Via
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
↗
February 08, 2022
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates for Osteoarthritis and other pain indications.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 08, 2022
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 07, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 04, 2022
Gainers Quidel (NASDAQ:QDEL) shares incre...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
February 01, 2022
Gainers Epizyme (NASDAQ:EPZM) shares incr...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 27, 2022
Gainers Avidity Biosciences (NASDAQ:RNA) s...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 18, 2022
Gainers DBV Technologies (NASDAQ:DBVT) sh...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
January 07, 2022
Gainers ContraFect (NASDAQ:CFRX) stock mo...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 06, 2022
Gainers ContraFect (NASDAQ:CFRX) stock in...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.